Our research in Edinburgh

What we are doing now

Our researchers in Edinburgh have everything they need to tackle cancer. From the best equipment to plenty of people to collaborate with, they are breaking new ground every day.

For example, Professor David Cameron is running important clinical trials to find the best way to treat people with breast cancer.

Professor Malcolm Dunlop is studying the faulty genes that underpin bowel cancer, to understand how our genes influence the risk of developing the disease and the chances of surviving it.

Dr Steve Pollard and his team are developing potential new treatments for the most common type of brain tumour in adults, known as glioblastoma multiforme.

And Dr Sara Erridge is running a clinical trial in Edinburgh to find the best way to treat a type of brain tumour called glioma.

How we’ve made a difference so far

• Edinburgh drug discovery scientists recently pioneered a potentially new way of delivering chemotherapy more precisely to tumours.
• The pivotal breast cancer clinical trial that led to global marketing authorisation of the drug lapatinib was run from our Edinburgh Centre.
• We supported research in Edinburgh that led to the identification of a unique population of ovarian cancer patients and helped develop a new personalised medicine approach to these ovarian cancer patients.
• Our researchers in Edinburgh discovered two important molecules that help cancer cells cheat death. Understanding how to manipulate these molecules could help our scientists find new ways to effectively destroy cancer cells and lead to life saving treatments.